The explosion of GLP-1 drugs has created a gray zone for pregnancy. That recently prompted the American College of Obstetricians and Gynecologists to issue <a href="https://www.acog.org/clinical/guidance/practice-advisory/2026/10/use-of-glucagon-like-peptide-1-receptor-agonists-in-pregnancy-and-lactation/"target="_blank" >its first ever guidance</a> on the topic. In a twist, the drugs may boost fertility for some, leading to more pregnancies – a phenomenon known on social media as “Ozempic babies”. But doctors caution against using the drugs during pregnancy itself. In fact, the more we looked into this story, the more twists and nuances we found. So, we brought Dr. <a href="https://www.ohsu.edu/providers/amy-valent-do"target="_blank" >Amy Valent</a> of Oregon Health and Science University onto the show to break down the latest on what’s known about how these drugs affect fertility and pregnancy.  Interested in more health news? Email us your question at <a href="mailto:shortwave@npr.org"target="_blank" >shortwave@npr.org</a>. Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at <a href="http://plus.npr.org/"target="_blank" >plus.npr.org</a>. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences. <a href="https://www.npr.org/about-npr/179878450/privacy-policy">NPR Privacy Policy</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

An ‘Ozempic baby boom’? The GLP-1 pregnancy plot twist

Short Wave

AI Chapters

AI Insights

Reviews